REPL is up 8.81% today. Volume is 2.04M vs a 30-day average of 1.97M (1.04x).
Replimune Group, Inc. is scheduled to report earnings Wed, Nov 4, 2026. Analysts expect EPS of $-0.78. Stocks often move sharply on earnings day.
WOBURN, Mass., Oct. 22, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a commercial stage biotechnology company pioneering the development of novel oncolytic immun…
Replimune Group has seen its share price move sharply in recent years, which naturally puts the spotlight on what the current US$10.86 level really represents. The key issue for y…
With limited cash runway and significant competition, Replimune remains a high-risk investment with uncertain near-term upside. Click for more on REPL.